Parkin Antikörper (N-Term)
PARK2
Reaktivität: Drosophila melanogaster
WB, ELISA
Wirt: Kaninchen
Polyclonal
unconjugated
-
-
Target
Alle Parkin (PARK2) Antikörper anzeigen
-
Parkin (PARK2)
(Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2))
-
Bindungsspezifität
-
N-Term
-
Reaktivität
-
Drosophila melanogaster
-
Wirt
-
Kaninchen
-
Klonalität
-
Polyklonal
-
Konjugat
-
Dieser Parkin Antikörper ist unkonjugiert
-
Applikation
-
Western Blotting (WB), ELISA
-
Verwendungszweck
-
Rabbit polyclonal antibody raised against synthetic peptide of park.
-
Kreuzreaktivität
-
Drosophila melanogaster
-
Immunogen
-
A synthetic peptide (conjugated with KLH) corresponding to N-terminus of Drosophila park.
-
Top Product
-
Discover our top product PARK2 Primärantikörper
-
-
-
Applikationshinweise
-
ELISA (1:1000)
Western Blot (1:50-100)
The optimal working dilution should be determined by the end user.
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Format
-
Liquid
-
Buffer
-
In PBS (0.09 % sodium azide)
-
Konservierungsmittel
-
Sodium azide
-
Vorsichtsmaßnahmen
-
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
-
4 °C,-20 °C
-
Informationen zur Lagerung
-
Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
Zhong, Tan, Zhou, Yu, Zhou: "RING finger ubiquitin-protein isopeptide ligase Nrdp1/FLRF regulates parkin stability and activity." in: The Journal of biological chemistry, Vol. 280, Issue 10, pp. 9425-30, (2005) (PubMed).
Pesah, Pham, Burgess, Middlebrooks, Verstreken, Zhou, Harding, Bellen, Mardon: "Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress." in: Development (Cambridge, England), Vol. 131, Issue 9, pp. 2183-94, (2004) (PubMed).
Haywood, Staveley: "Parkin counteracts symptoms in a Drosophila model of Parkinson's disease." in: BMC neuroscience, Vol. 5, pp. 14, (2004) (PubMed).
-
-
Target
-
Parkin (PARK2)
(Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2))
-
Andere Bezeichnung
-
park (PARK2 Produkte)
-
Synonyme
-
CG10523 antikoerper, Dmel\\CG10523 antikoerper, Dpark antikoerper, SD01679 antikoerper, dpk antikoerper, AR-JP antikoerper, LPRS2 antikoerper, PDJ antikoerper, PRKN antikoerper, Park antikoerper, Prkn antikoerper, si:ch211-123f21.1 antikoerper, zgc:112390 antikoerper, pdr-1 antikoerper, PARK2 antikoerper, parkin antikoerper, parkin RBR E3 ubiquitin protein ligase antikoerper, Parkinson disease (autosomal recessive, juvenile) 2, parkin antikoerper, park antikoerper, PRKN antikoerper, Prkn antikoerper, prkn antikoerper, CpipJ_CPIJ014867 antikoerper, Park2 antikoerper
-
Gen-ID
-
40336
-
Pathways
-
Autophagie, Ubiquitin Proteasome Pathway
-